NDC 0703-1995
Epoprostenol Sodium
Epoprostenol Sodium
Epoprostenol Sodium is a Intravenous Injection, Powder, For Solution in the Human Prescription Drug category. It is labeled and distributed by Teva Parenteral Medicines, Inc.. The primary component is Epoprostenol Sodium.
| Product ID | 0703-1995_1916c211-a026-4b81-9909-35962a9ae003 |
| NDC | 0703-1995 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Epoprostenol Sodium |
| Generic Name | Epoprostenol Sodium |
| Dosage Form | Injection, Powder, For Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2008-04-23 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA078396 |
| Labeler Name | Teva Parenteral Medicines, Inc. |
| Substance Name | EPOPROSTENOL SODIUM |
| Active Ingredient Strength | 2 mg/1 |
| Pharm Classes | Prostacycline Vasodilator [EPC],Prostaglandins I [CS],Vasodilation [PE] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |